CX516 Completed Phase 2 Trials for Alzheimer's Disease (AD) / Dementia Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00001662 | Treatment of Alzheimer's Disease With CX516 (Ampalex) |
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00001662 | Treatment of Alzheimer's Disease With CX516 (Ampalex) |